BioMed Research International / 2014 / Article / Fig 4

Research Article

Mesenchymal Stem Cells Expressing Brain-Derived Neurotrophic Factor Enhance Endogenous Neurogenesis in an Ischemic Stroke Model

Figure 4

MSCs-BDNF increased endogenous neurogenesis in the ischemic stroke model. (a) Area of the SVZ exhibiting migrating neuroblasts (DCX; green). Coexpression of BrdU (red) and DCX (green) in cells of the SVZ. Arrows indicate double-positive (BrdU/DCX) cells. MSCs-BDNF led to an increase in the number of new neuronal cells after cell transplantation (scale bar: (A)–(I); 20 μm, (J)–(L); 10 μm). (b) Significant increase in the number of BrdU+ cells in the SVZ of the MSCs and MSCs-BDNF groups compared with the PBS group (* ). (c) Quantification of DCX immunoreactivity (* and ** ). (d) Quantification of DCX/BrdU double-positive cells in the SVZ (* and ** ). (e) Coexpression of BrdU (red) and NeuN (mature neuronal marker; green) in the ipsilateral striatum at 4 weeks after MCAO (scale bar: 10 μm). (f) Quantification of NeuN/BrdU double-positive immunoreactivity (* and ** ).
129145.fig.004a
(a)
129145.fig.004b
(b)
129145.fig.004c
(c)
129145.fig.004d
(d)
129145.fig.004e
(e)
129145.fig.004f
(f)